This funding will accelerate QT Medical's market penetration, global expansion, product pipeline development, and long-term strategic planning.

The Series B financing was led by CDIB Capital and Taiwania Capital. Cathay Capital, BE Capital, TMU Biomed, and existing investor, Quanta Computer, also joined the Series B round.

QT Medical is a medical device company specializing in cloud-connected cardiac monitoring devices. QT Medical aims to provide improved cardiac devices and services to revolutionize the care of patients with heart disease. Its flagship product, the Personal Cardiac Assistant (PCA 500)™, is the only hospital-grade, resting 12-lead ECG device cleared by the FDA and CE marked for both professional and patient use.